Patrick J. van der Voorn
Papers
1
Total Citations
27
H-Index
1
About
Patrick J. van der Voorn is a leading researcher in oncologic imaging, with a primary focus on improving the detection and characterization of prostate cancer. His work centers on the integration of advanced molecular imaging techniques, specifically PSMA-targeted PET, with high-field multiparametric MRI. Dr. van der Voorn’s major contribution lies in demonstrating the superior diagnostic accuracy of hybrid [18F]DCFPyL PET/MRI over conventional mpMRI alone for identifying clinically significant prostate cancer. His landmark study, the ProStaPET trial (2021, 27 citations), prospectively validated this approach by correlating imaging findings with whole-mount histopathology from radical prostatectomy specimens. This work provides critical evidence that combined PET/MRI can reduce false positives and better localize aggressive tumors, potentially guiding more precise biopsies and treatment planning. By establishing a rigorous, histopathology-confirmed benchmark, Dr. van der Voorn has advanced the clinical translation of PSMA-PET/MRI, offering a powerful tool to improve risk stratification and patient outcomes in prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1